作者: Elizabeth Stewart , Anang Shelat , Cori Bradley , Xiang Chen , Sara Federico
DOI: 10.1016/J.YDBIO.2015.02.002
关键词:
摘要: Abstract Neuroblastoma is a pediatric cancer of the developing sympathoadrenal lineage. The tumors are known to develop from adrenal gland or paraspinal ganglia and have molecular cellular features sympathetic neurons such as dense core vesicles catecholamine production. Here we present detailed molecular, cellular, genetic epigenetic characterization an orthotopic xenograft derived high-risk stage 4 neuroblastoma patient. Overall, xenografted tumor retained high risk primary showed aggressive growth metastasis in mouse. Also, genome was preserved with no additional copy number variations, structural variations aneuploidy. There were 13 missense mutations identified that not patient׳s there new nonsense mutations. None acquired genes. We also demonstrate feasibility using test standard care chemotherapy targeted therapeutics. Finally, optimized approach produce cultures xenografts for high-throughput drug screening which can be used combinations therapeutic agents neuroblastoma.